These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 742869)

  • 1. Pharmacokinetics of mezlocillin in healthy volunteers.
    Bergan T
    Antimicrob Agents Chemother; 1978 Dec; 14(6):801-6. PubMed ID: 742869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of intravenous mezlocillin in chronic hemodialysis patients.
    Francke E; Mehta S; Neu HC; Appel GB
    Clin Pharmacol Ther; 1979 Aug; 26(2):228-31. PubMed ID: 455891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment.
    Mangione A; Boudinot FD; Schultz RM; Jusko WJ
    Antimicrob Agents Chemother; 1982 Mar; 21(3):428-35. PubMed ID: 6213190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
    Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
    Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.
    Tjandramaga TB; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1978 Dec; 14(6):829-37. PubMed ID: 742871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
    Wenzler E; Ellis-Grosse EJ; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of mezlocillin.
    Issell BF; Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1978 Feb; 13(2):180-3. PubMed ID: 646340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mezlocillin disposition in chronic hemodialysis patients.
    Janicke DM; Mangione A; Schultz RW; Jusko WJ
    Antimicrob Agents Chemother; 1981 Nov; 20(5):590-4. PubMed ID: 6459760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of mezlocillin and carbenicillin.
    Pancoast SJ; Neu HC
    Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of low- and high-dose ticarcillin.
    Guglielmo BJ; Flaherty JF; Batman R; Barriere SL; Gambertoglio JG
    Antimicrob Agents Chemother; 1986 Sep; 30(3):359-60. PubMed ID: 3777901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.